Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.92 USD | -0.11% | -15.61% | +12.06% |
Apr. 24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
Apr. 24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Chart calendar Centessa Pharmaceuticals plc
Upcoming events on Centessa Pharmaceuticals plc
Past events on Centessa Pharmaceuticals plc
2024-03-28 04:28 pm | Q4 2023 Earnings Release |
2024-03-13 10:30 am | Guggenheim Healthy Altitudes Summit |
2024-03-11 10:00 am | Leerink Partners Global Biopharma Conference |
2024-03-05 02:50 pm | TD Cowen Health Care Conference - Fireside Chat |
2024-02-09 07:45 am | American Society of Hematology Meeting - Session Number / Name: OR11 |
2024-02-07 09:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
2024-01-10 07:30 pm | JPMorgan Healthcare Conference |
2023-12-10 09:00 am | American Society of Hematology Meeting - Abstract Number: 2619 |
2023-11-28 04:40 pm | Evercore ISI HealthCONx Conference |
2023-11-15 05:30 am | Jefferies London Healthcare Conference |
2023-11-13 04:05 pm | Q3 2023 Earnings Release |
2023-10-25 09:45 am | World Sleep Congress - Ref number: O25 |
2023-10-24 02:22 pm | World Sleep Congress - Ref number: S56 |
2023-10-19 | World Sleep Congress |
2023-09-12 04:15 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
2023-08-14 07:00 am | Q2 2023 Earnings Release |
2023-06-22 08:00 am | Annual General Meeting |
2023-06-13 07:40 pm | Goldman Sachs Global Healthcare Conference |
2023-06-09 10:30 am | Jefferies Global Healthcare Conference |
2023-05-12 07:00 am | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 6,85 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -374 -150 -148.66% | -212 -205 -3.29% | -170 -175 2.79% | -163 |
EBIT Million USD | Released Forecast Spread | 0,00 | -374 -156 -139.89% | -212 -210 -1.2% | -171 -177 3.49% | -175 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -176 -198 10.99% | -197 |
Net income Million USD | Released Forecast Spread | -3,15 | 0,00 0,00 - | -216 -217 0.37% | -151 -161 6.06% | -195 |
EPS USD | Released Forecast Spread | -0,40 | 0,00 0,00 - | -2,31 -2,30 -0.43% | -1,57 -1,66 5.28% | -1,82 |
Announcement Date | 21/04/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 6,85 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -58,3 -51,8 -12.43% | -53,2 -63,0 15.53% | -68,4 -52,4 -30.5% | -49,0 -53,0 7.54% | -41,6 -46,9 11.21% | -48,9 -41,0 -19.14% | -47,0 -48,9 3.75% | -40,2 -48,8 17.55% | -35,2 -49,5 28.98% | -43,4 | -45,2 | -46,8 | -55,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,9 -51,5 4.98% | -41,5 -53,4 22.33% | -35,7 -57,5 37.93% | -44,0 | -47,0 | -51,0 | -55,0 | ||||||
Net income Million USD | Released Forecast Spread | -43,2 -42,0 -2.79% | -50,7 -34,0 -49.16% | -24,9 -44,8 44.39% | -38,6 -50,3 23.22% | -36,8 -47,3 22.18% | -43,0 | -47,0 | -49,5 | -55,0 | ||||
EPS USD | Released Forecast Spread | -0,45 -0,44 -2.27% | -0,53 -0,36 -47.22% | -0,26 -0,47 44.68% | -0,40 -0,52 22.33% | -0,38 -0,48 21.24% | -0,42 | -0,45 | -0,44 | -0,48 | ||||
Announcement Date | 30/03/22 | 16/05/22 | 10/08/22 | 10/11/22 | 30/03/23 | 12/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
Past sector events for Centessa Pharmaceuticals plc
2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CNTA Stock
- Calendar Centessa Pharmaceuticals plc